In our previous studies, frequently relapsing EGPA patients, defined as patients who relapse at least once every 2 years after an initial period of remission, had decreased numbers of Treg cell counts, CD19+ B cells, and a lower serum IgG concentration than those who did not experience frequent relapses. This evidence concerns the gene CD19 and eosinophilic granulomatosis with polyangiitis.